The following study describes a methodology to establish, control, and characterize an aerosolized bioburden within a test chamber and determine the settling rate of the bioburden.
Daniel Py
Advertisement
Daniel Py is chairman and CEO, MedInstill Development.
Articles by Daniel Py
Advertisement
Latest Updated Articles
Establishing Correlation Between Aerosol and Surface Microbial PopulationsPublished: February 2nd 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CPHI Frankfurt 2025: Regulatory Challenges for Global Manufacturing of Vaccines
2
AI and Accelerated Computing Propel the Biopharma Ecosystem Forward
3
Takeda Talks at CPHI Frankfurt 2025 About Smart Pharma Packaging Impacts
4
CPHI Frankfurt 2025: The Current API Market
5
